Encompass Health announces launch of private offering of 5.875% senior notes due 2034

Rhea-AI Summary

Encompass Health (NYSE: EHC) has launched a private offering of an additional $100 million aggregate principal amount of 5.875% senior notes due 2034. These Additional Notes reopen the 5.875% notes first issued in May 2026 and will form the same class, with identical terms except for issuance date and offering price.

The notes will be senior unsecured and jointly and severally guaranteed by subsidiaries that guarantee borrowings under the company’s credit agreement and other capital markets debt. Encompass Health plans to use net proceeds, together with cash on hand, to repay outstanding amounts under its senior secured revolving credit facility. The offering is a private placement under Rule 144A and Regulation S and is not registered under the Securities Act.

Positive

• $100 million additional 5.875% senior notes due 2034 to refinance revolver borrowings
• Refinancing senior secured revolving credit facility with longer-term fixed-rate notes
• New notes guaranteed on a senior unsecured basis by key subsidiaries

Negative

• Issuance of an additional $100 million in senior notes increases outstanding debt
• New 5.875% coupon on $100 million adds fixed interest expense until 2034

News Explained

The offering has commenced but remains subject to market and other conditions, so the release does not establish a completed financing or a committed $100 million addition to the notes.

Market Context

The tag-matched record showed an average move of -0.4% across 2 offerings. For this debt refinancing...

Analysis

The tag-matched record showed an average move of -0.4% across 2 offerings. For this debt refinancing, that precedent frames the financing as a recurring capital-markets event; insider Net Selling remains a risk to monitor.

Key Figures

Additional Notes Principal: $100 million Interest Rate: 5.875% Maturity: 2034 +1 more

4 metrics

Additional Notes Principal $100 million additional senior notes offering

Interest Rate 5.875% senior notes due 2034

Maturity 2034 senior notes maturity year

Existing Notes Issuance May 2026 original issuance of the existing 5.875% senior notes

Previous Private placement,offering Reports

2 past events · Latest: May 14 (Negative)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
May 14	senior notes offering	Negative	-0.6%	5.875% notes issued to refinance debt and repay revolving credit facility
May 14	senior notes offering	Negative	-0.2%	$500 million notes launched to redeem 2028 notes and repay revolving credit facility

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior tag-matched offerings both had negative 24-hour reactions, averaging -0.4%.

Key Terms

senior unsecured, qualified institutional buyers, rule 144a, regulation s

4 terms

senior unsecured financial

"The Additional Notes will be jointly and severally guaranteed on a senior unsecured basis"

Senior unsecured is a type of loan or bond that has priority over other unsecured obligations for repayment if a company runs into financial trouble, but it is not backed by specific assets as collateral. Think of it as being near the front of a line to get paid, but without a pledged item to seize if the borrower defaults; that higher repayment priority typically makes it less risky than subordinated debt but more risky than secured debt, which influences the interest rate investors demand.

qualified institutional buyers regulatory

"offered in the United States only to persons reasonably believed to be qualified institutional buyers"

Qualified institutional buyers are large organizations, like big investment firms or banks, that are allowed to buy certain types of investment opportunities not available to everyday investors. Their size and experience matter because it ensures they understand and can handle complex financial deals, making markets more efficient and secure.

rule 144a regulatory

"pursuant to Rule 144A under the Securities Act of 1933"

Rule 144A is a regulation that makes it easier for companies to sell private bonds to large investors without going through all the usual rules that apply to public sales. It matters because it helps companies raise money more quickly and privately, often attracting big investors looking for special deals.

regulation s regulatory

"outside the United States pursuant to Regulation S under the Securities Act"

Regulation S is a set of rules that allows companies to sell securities (like shares or bonds) to investors outside the United States without having to follow all U.S. securities laws. It matters because it makes it easier for companies to raise money from international investors while still complying with U.S. regulations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BIRMINGHAM, Ala., Aug. 10, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it has commenced a private offering of an additional $100 million in aggregate principal amount of 5.875% senior notes maturing in 2034 (the "Additional Notes"), subject to market and other conditions. The Additional Notes will constitute a reopening of the Company's 5.875% senior notes maturing in 2034 originally issued in May 2026 (the "Existing Notes") and will be treated as the same class as, and will have the same terms (other than the date of issuance and the offering price) as, the Existing Notes. The Additional Notes will be jointly and severally guaranteed on a senior unsecured basis by all of the Company's existing and future subsidiaries that guarantee borrowings under the Company's credit agreement and other capital markets debt.

The Company intends to use the net proceeds from the offering of the Additional Notes, together with cash on hand, to repay outstanding amounts under the Company's senior secured revolving credit facility.

The Additional Notes will be offered in the United States only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain non-U.S. persons in transactions outside the United States pursuant to Regulation S under the Securities Act. The offer and any sale of the Additional Notes and the related guarantees have not been and will not be registered under the Securities Act or any state securities laws, and the Additional Notes may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws.

This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security and does not constitute an offer, solicitation or sale of any security in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Encompass Health 
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 176 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized by Newsweek as America's Most Awarded Leader in Inpatient Rehabilitation and is ranked among Fortune's World's Most Admired Companies™ and Forbes' America's Best Companies. It is also recognized by Becker's Healthcare and Modern Healthcare as a top healthcare employer. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.

From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health. 

Forward-looking statements 
Statements contained in this press release which are not historical facts, such as the likelihood, timing and effects of the completion of the private offering of the Additional Notes, are forward-looking statements. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, Encompass Health's ability to complete the offering of the Additional Notes on the terms described or at all; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; a significant disruption in the capital markets or economy; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including its Form 10-K for the year ended Dec. 31, 2025 and Forms 10-Q for the quarters ended March 31, 2026 and June 30, 2026.

Media contact:
Polly Manuel | 205-970-5912
Media@encompasshealth.com

Investor relations contact:
Mark Miller | 205-970-5860
Mark.Miller@encompasshealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-announces-launch-of-private-offering-of-5-875-senior-notes-due-2034--302847109.html

SOURCE Encompass Health Corp.

FAQ

What did Encompass Health (EHC) announce about its senior notes on August 10, 2026?

Encompass Health announced a private offering of an additional $100 million of 5.875% senior notes due 2034. According to the company, these Additional Notes reopen its existing 5.875% 2034 notes first issued in May 2026 and share substantially the same terms.

What are the key terms of Encompass Health’s new 5.875% senior notes due 2034 (EHC)?

The Additional Notes carry a 5.875% coupon and mature in 2034, matching Encompass Health’s existing 2034 notes. According to the company, they form the same class and share the same terms, except for issuance date and offering price.

How will Encompass Health (NYSE: EHC) use the proceeds from the $100 million private notes offering?

Encompass Health intends to use the net proceeds from the Additional Notes, together with cash on hand, to repay outstanding amounts under its senior secured revolving credit facility. According to the company, the transaction effectively refinances existing revolving credit borrowings.

Who can buy Encompass Health’s new 5.875% senior notes due 2034 (EHC)?

The Additional Notes are being offered privately in the United States to qualified institutional buyers under Rule 144A. According to Encompass Health, certain non-U.S. persons may also participate in transactions outside the United States under Regulation S of the Securities Act.

Are Encompass Health’s new $100 million senior notes (EHC) registered with the SEC?

No, the Additional Notes and related guarantees are not registered under the Securities Act or state securities laws. According to Encompass Health, they may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

How are Encompass Health’s Additional Notes guaranteed by its subsidiaries (EHC)?

The Additional Notes will be jointly and severally guaranteed on a senior unsecured basis by all existing and future subsidiaries that guarantee borrowings under Encompass Health’s credit agreement and other capital markets debt. According to the company, this aligns guarantees with its broader debt structure.